Send me a link:

*Text messaging rates may apply.

 Dow Up 0.04% Nasdaq Up 0.40%

Alkermes plc (ALKS)

-NasdaqGS
45.79 Down 0.42(0.91%) 9:30AM EDT - Nasdaq Real Time Price
Prev Close:46.21
Open:N/A
Bid:N/A
Ask:N/A
1y Target Est:50.92
Beta:1.5
Earnings Date:Jul 24 - Jul 25 (Est.)
Day's Range:45.76 - 46.07
52wk Range:28.86 - 54.25
Volume:5,129
Avg Vol (3m):791,389
Market Cap:6.62B
P/E (ttm):N/A
EPS (ttm):-0.03
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Comparison

Symbol% ChgMkt Cap
ALKSDown 0.91%6.62B
ABTDown 0.02%64.52B
LLYDown 0.23%68.76B
GSKDown 0.02%120.42B

Key Statistics

Forward P/E (1 yr):66.97
P/S (ttm):12.28
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-14) :0.49
Quarterly EPS Est (Jun-14) :0.14
Mean Recommendation*:2.4
PEG Ratio (5 yr expected):7.20

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Alkermes Public Limited Company, an integrated biopharmaceutical company, develops medicines that enhance patient outcomes. The company offers RISPERDAL CONSTA for schizophrenia and bipolar I disorder; INVEGA SUSTENNA to treat schizophrenia; AMPYR... View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback